Introduction
Interferons (IFNs) have an unusual inhibitory effect on some membrane viruses (Friedman & Pitha, 1984) which is expressed in two major ways: inhibition of virus assembly, release and budding, as reported for most murine leukaemia viruses (MLVs) (Friedman et al., 1975) , mouse mammary tumour viruses (Yagi et al., 1980) , bovine parainfluenza virus (PIV-3) (Panigrahi et al., 1988) and herpes simplex virus type 1 (HSV-1) (Chatterjee et al., 1985) , and recently (Ho et al., 1985; Poli et al., 1989) human immunodeficiency virus (HIV) replication in T cells; or a small decrease in the production of virus particles together with a marked reduction in the infectivity of released virions, as reported in some infections with MLV (Friedman & Pitha, 1984) , vaccinia virus (Esteban, 1984) , HSV-1 (Mufioz & Carrasco, 1984) and vesicular stomatitis virus (VSV) (Maheshwari & Friedman, 1979; Drebot et al., 1984) , and HIV infection of macrophages (Gendelman et al., 1990) .
Earlier, we reported that there is an approximately 200-fold reduction of the titre of infectious VSV in mouse LR cells treated with 30 units/ml of IFN ; however, virus particle-associated RN A, nucleocapsid protein and viral transcriptase are inhibited less than 10-fold (Maheshwari & Friedman, 1979) . These results suggest that IFN treatment induces the production of VSV particles of low infectivity. The reduced infectivity of VSV particles released from IFN-treated cells is not due to defective interfering particle production, because only 42S viral RNA was virion-associated; in addition, virions produced by IFN-treated cells do not interfere with the growth of wild-type VSV in BHK or LB cells. VSV released from IFN-treated cells is, however, selectively deficient in viral glycoprotein (G) and membrane protein (Maheshwari & Friedman, 1980; Maheshwari et al., 1980a) . As might be predicted from such studies, IFN-treated cells release VSV particles deficient in G spikes (Maheshwari et al., 1980b) . These results certainly would account for the reduced infectivity of VSV produced by IFN-treated cells, as G is required for infectivity. Jay et al. (1983) have reported that VSV G is produced, and is present in the same proportion to other virus proteins, in the cytoplasm of both IFN-treated and control cells; however, only a very small percentage of the G produced is incorporated into the released virus. In addition, IFN treatment inhibits the transport of G from 0001-0132 © 1991 SGM the trans-Golgi network (TGN) to the plasma membrane; double-labelling, qualitative and quantitative immunofluorescence studies show that VSV G from IFN-treated cells co-localizes with wheatgerm agglutinin bound to the Golgi complex (Singh et al., 1988) .
In the present study, we have investigated the possible mechanism of inhibition of VSV G transport by IFN. Our results suggest that an IFN-induced increase in intracellular pH (pHi) may be important in the inhibition of the transport of VSV G to the plasma membrane.
Methods
Cell lines, IFNs and viruses. A subclone, l 1, was derived from the mouse LB cell line by a single cell cloning method (Singh et al., 1988) . LB (originally obtained from D. C. Burke, University of Warwick, Coventry, U.K.), Veto and HeLa cell lines (both originally obtained from the NIH media section) were maintained in Eagle's MEM (EMEM) supplemented with 10~ foetal bovine serum. Swiss 3T3 mouse cells (obtained from the Imperial Cancer Research Fund, U.K.) were maintained in Dulbecco's MEM with 10% foetal calf serum. Recombinant murine IFN-fl and human IFN-cqa (Roferon A) were obtained from Toray Industries and Hoffman La Roche respectively.
The Indiana strain of VSV and encephalomyocarditis virus (EMCV) (originally obtained from C. Buckler, NIAID, NIH, Bethesda, Md., U.S.A.) were plaque-purified and passaged at multiplicities of 0.01 in Vero and La cells, respectively. The VSV pool was assayed by determining its c.p.e, in Vero cells; the titre was 8 x 108 TCIDs0/ml. The EMCV stock was assayed by determining its c.p.e, in LB cells; the titre was 2 × 109 TCIDs0/ml.
Reagents. Ammonium chloride, chloroquine (CHL) and methylamine (MAM) were purchased from Sigma; dansylcadaverine (DCA) was obtained from Fluka Chemical Corporation; carboxy-seminaphthorhodafluor-1 (SNARF-1), sodium-binding benzofuran isophthalate (SBFI) and pluronic acid were purchased from Molecular Probes; fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse IgG was obtained from Cappel; 3-(2,4-dinitroanilino)-3'-amino-N-methyldipropylamine (DAMP) and monoclonal mouse anti-dinitrophenyl (DNP) IgG were kindly provided by Dr R.G.W. Anderson, University of Texas, Dallas, Tx, U.S.A.; (5-N-2,3-dihydroxypropyl acetamido)-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)isophthalamide (Nycodenz) was procured from Nycomed.
Assay for antiviral activity. The antiviral activity of IFN was assayed as described previously (Maheshwari & Friedman, 1979) . Briefly, cells were grown in 96-well microtitre plates until 50~ confluent and were treated in quadriplicate with IFN for 16 h. IFN was then removed, and cells were washed and infected with VSV or EMCV for 1 h at a multiplicity of 5 TCIDso/cell. Unadsorbed virus was removed, cells were washed and fresh medium was added with or without primary amines as indicated. The cells were incubated for a further 16 h and examined under a light microscope for c.p.e. Supernatants from replicate wells were pooled and virus yields determined. Data are plotted as inhibition of virus yield (log10).
Immunofluorescence studies. LB and HeLa cells were grown on coverslips in six-well plates and treated with various concentrations of mouse IFN-fl or human IFN-ct2a, respectively, overnight. IFN was then removed, and the cells were washed and infected with 5 TCIDs0 of VSV for 1 h. Unadsorbed virus was then removed and fresh medium with or without primary amines added. After 8 h of infection, the cells were fixed in chilled acetone. Immunofluorescence staining was performed with an anti-VSV G monoclonal antibody (kindly provided by Heinz Arnheiter, NIH, Bethesda, Md., U.S.A.) followed by fluorescein-labelled goat anti-mouse IgG (Kirkegaard & Perry Laboratories) as previously described (Singh et al., 1988) . Untreated and uninfected cells were employed to demonstrate the specificity of staining of G. Samples were viewed and photographed using a Zeiss photomicroscope IIl with a 63 x oil-immersion lens.
Biochemical localization of VSV in TGN. Control, DCA-and IFNtreated, VSV-infected HeLa cells were incubated for 5 h at 37 °C after virus adsorption. Cells were washed once with methionine-free EMEM, incubated for 1 h in the same medium and then labelled with [3sS]methionine (50 ~tCi/ml). After a 20 min pulse, cells were washed with EMEM containing a 10-fold excess of unlabelled methionine and 20 ~tg/ml cycloheximide, and then incubated in the same medium for another 2 h.
Cells were subjected to subcellular fractionation on a 10 to 45 ~ linear sucrose gradient 8 h post-infection (p.i.) (de Curtis et al., 1988) . Each fraction was analysed for lysosomal reductase (/~-N-acetylglucosaminidase) (Koldvosky & Palmieri, 1971) and mitochondrial reductase (succinate-I NT(3-4(-iodophenyl)2-4(nitrophenyl)-5-phenyltetrazolium chloride) (Pennington et al., 1961) , and TGN (uridine-diphosphategalactosyl-glycoprotein galactosyltransferase) (Pesonen et al., 1984) markers.
TGN enzyme (uridine disphosphate-galactosyl-glycoprotein galactosyltransferase)-rich fractions obtained by sucrose gradient fractionation were pooled and pelleted at 100 000 g for 2 h. A discontinuous 10 to 40~ Nycodenz gradient was layered on the pellet and ultracentrifuged at 100000g for 10 h, and then the gradient was fractionated. Each fraction was analysed for subcellular markers and subjected to 10~ SDS PAGE (Laemmli, 1970) for the localization of G.
Proteins were transferred to nitrocellulose paper from an SDSpolyacrylamide slab gel by Western blotting. G was immunoblotted using anti-G monoclonal antibodies and streptavidin-biotinylated alkaline phosphatase as a substrate. Since the proteins had been labelled with [3sS]methionine, stained strips were cut out and exposed to a Kodak-SB-J X-Omat film.
pHi measurement, pHi was measured using SNARF-I, a sensitive indicator, with the help of laser spectroscopy (Bassnett et al., 1990) . Fluorescence emission spectra from cells exposed to SNARF-l (excited at 514nm) were pH-sensitive, with protonated and unprotonated emissions maximal at 587 and 636 nm respectively. The change in the ratio of the emission intensity of these two peaks reflected the alteration in pHi.
Cells were treated with IFN and/or primary amines as indicated, washed twice with albumin-free RPMI 1640 medium containing 25 mM-HEPES and 10~tl of 1 mM-SNARF-1 was added in 1 ml of medium to produce a final concentration of 101xM-SNARF-1. The dishes were incubated at 37 °C for 40 rain in a CO: incubator. The dye was fully loaded within 30 to 40 min and the ceils were washed thoroughly in the albumin-free medium to remove excess unloaded dye.
Intracellular fluorescence was measured on an ACAS 470 scanning laser microscope (Meridian Instruments). The ACAS was equipped with a computer-controlled scanning stage which could be moved in fixed increments (step size) along the x-and y-axes. At each stage coordinate, the focused beam was turned on for 8 microseconds, and the fluorescence was measured simultaneously at the two emission maxima of 636 and 587 nm. The fluorescence intensity at each wavelength was detected with a photomultiplier tube (PMT). By moving the stage, we were able to scan the sample from an orthogonal array of coordinates and construct two digital images of the specimen corresponding to the two emission maxima. Such images took 5 s to construct and were collected every 30 s. For each image, the background fluorescence at each wavelength was measured on a cellfree portion of the dish and subtracted from the signal obtained from cells. After subtraction of the background fluorescence, the total pixel intensity at 636 nm was divided by that at 587 nm to give an emission ratio, which was then plotted against time. The step size in each experiment was 2 Ixm and the gain on two PMTs was adjusted independently to give approximately equal signals at resting pHi. The phi was determined from titration curves generated using the proton ionophore nigericin dissolved in HEPES buffer with high potassiumcontaining 30 mM-HEPES, 130 mM-KCI and 1 mM-MgCI2. Nigericin is a K+-H + antiporter that allowed the pHi to equilibrate with the extracellular pH under conditions in which the K ÷ concentration gradient across the membrane is abolished (Thomas et al., 1979) . This technique enabled us to determine the pHi in individual cells.
Localization of intracellular distribution of DAMP. Mouse La and
HeLa cells were grown on coverslips until 50% confluent and treated with mouse IFN-~ [30 international units (IU)/ml] or human IFN<t2a (100 IU/ml), and/or CHL (100 p.M). DAMP was localized as described by Anderson & Pathak (1985) . Briefly, monolayers were incubated with DAMP (30 p.M) for 30 rain at 37 °C and then fixed for 15 min at room temperature in 3 % (w/v) paraformaldehyde. Cells were permeabilized with Triton X-100, treated with 50 ~tl monoclonal mouse anti-DNP IgG (50 ~tg/ml) and incubated for 60 min. After washing extensively, they were incubated with 50 ~tl FITC-conjugated rabbit anti-mouse IgG for 60 min, washed and mounted on glass slides for viewing under a Zeiss fluorescence microscope to localize DAMP.
Measurement of free intracellular sodium ion concentration [Na~.
[Nai +] was measured using SBFI, a sodium-binding fluorescent indicator (Harootunian et al., 1989) . Cells were treated overnight with human IFN-ct2a, washed three times with serum-free RPMI 1640 medium buffered with 25 mM-HEPES and incubated with 10 ~tM-SBFI containing 0.1% pluronic acid for 90 min at 37 °C. The excess unloaded dye was removed by washing three times with serum-free RPMI 1640 medium. The procedure for measuring the fluorescence was the same as that for the pHi measurements, except that SBFI was excited using a u.v. argon laser (351 to 364 nm) and the total fluorescence from ceils in each field was measured, digitized, averaged and used as an index of the [Na~.
Results

Effect of IFN and/or primary amines on antiviral activity
LB and HeLa cells were treated for 16 h with mouse IFN-/~ (0 to 10 IU/ml) or human IFN-~za (0 to 100 IU/ml), respectively. IFN was then removed, and the cells were washed and infected with VSV or EMCV for 1 h; unadsorbed virus was removed after this time and the cultures were refed with fresh medium with or without various concentrations of DCA, NH4C1, CHL or MAM. The cultures were incubated for an additional 16 h, and cells in replicate wells were pooled and assayed for virus yield. At the concentrations used, primary amines had no significant inhibitory effect on the replication of VSV; however, when used in combination with various doses of IFN, there was a significant potentiation (five-to 1000-fold) of the antiviral activity of IFN against VSV, an enveloped virus (Fig. 1 ). Higher concentrations of primary amines also inhibited the infectivity of VSV (data not shown). The enhancement of antiviral activity was dependent on the cell and dose of IFN or primary amine used. No enhancement by primary amines of the antiviral activity of IFN against EMCV, a nonenveloped RNA virus, was seen.
Effect of lFN and/or primary amines on the accumulation of VSV G
Over 95 % of the untreated, infected LB and HeLa cells showed plasma membrane fluorescence 8 h p.i. with VSV, whereas fluorescence was localized in the perinuclear region of the cytoplasm in the majority of IFNtreated cells. Similarly, most G was localized intracellulady in cells treated with higher concentrations of various primary amines (Fig. 2) .
Lower doses of the primary amines by themselves did not appear to block the transport of VSV G to the plasma membrane; however, an enhancement in the intracellular accumulation of VSV G was seen in cells pretreated with IFN and lower doses of primary amines (data not presented).
Biochemical localization of G in the TGN
The effectiveness of sucrose density centrifugation for the purification of TGN was assessed by comparing the distribution of TGN marker across the gradient to that of markers for other subcellular compartments. Mitochondria and lysosome fractions were well separated; however, fractions rich in fl-N-acetylglucosaminidase and galactosyltransferase overlapped. The level of purification of galactosyltransferase obtained by sucrose gradient centrifugation was eightfold that of the postnuclear supernatant. Therefore, Nycodenz gradient separation was used to resolve the overlapping lysosome and TGN fractions, and for further purification of the TGN membranes.
As evident from Fig. 3 , the TGN (fractions 9 to 14) was separated from lysosomes (fractions 14 to 19). In addition, purification of the TGN marker achieved on a Nycodenz gradient was 20-fold that of the postnuclear supernatant. Since most VSV G from untreated cells was found in the sucrose gradient fractions enriched for plasma membrane, which are absent from the Nycodenz gradient preparations, the concentration of G (Fig. 4a ) appeared to be less on Nycodenz gradients of these controls; the G remaining was localized to lysosome enriched fractions 15 to 21. In IFN-treated cells, VSV Grich fractions collected from the Nycodenz gradient were TGN-enriched (Fig. 4) . Most of the G also accumulated in TGN-enriched fractions from DCA-treated cells; however, there was some G in other cellular compartments. Therefore, although both IFN and DCA treat-R. K. Maheshwari and others Immunoprecipitated G from fractions 9 to 14 was endonuclease H (endo H)-resistant, suggesting that it had been processed in TGN vesicles; however, Doms et al. (1989) have demonstrated that endo H-resistant peptides may also be associated with the medial Golgi body. Therefore, G was digested with neuraminidase and found to be fully sialylated, confirming that it was indeed TGN-associated.
Effect of lFN and~or primary amines on pHi
We quantified phi using SNARF-1, a sensitive fluorescent pH (pHi) probe. Mouse LB or HeLa cells were 
treated with mouse IFN-fl (30 IU/ml) or human IFN-~2a (100 IU/ml), respectively, for 16 h, or 100 ~tr4-DCA for 4 h. Cells were incubated with the primary amine for 16 h while the antiviral activity was studied; in this study, virus was titrated after 16 h because the effect of primary amine was reversible by its removal from the medium. However, cells were incubated with amines for 4 h for pHi studies because the effect of primary amines on pHi after 1 h was independent of time; therefore, it was not necessary to incubate the IFN-treated cells with amines for 16 h for phi studies. The phi in an untreated control, and IFN-or DCA-treated HeLa (a to c) or LB (d to f ) cells is shown in Fig. 5 . Each line represents the pHi of an individual cell within the same population. The resting pHi of untreated cells ranged from 7.0 to 7.1 (Fig.  5a, d ). DCA raised pHi by 0-8 units (Fig. 5b, e) and a significant rise in pHi was seen in both HeLa (0-79 units) and LB (0-58 units) cells following treatment with IFN ( Fig. 5c, f) . Dose-response studies with human IFN-0~Za (0 to 100 IU/ml) in HeLa cells indicated a maximum increase in pHi with doses of between 50 and 100 IU/ml. Kinetics studies in HeLa and LB cells showed that IFN treatment for 9 to 12 h was required to produce an optimal increase in pHi, and this correlated closely with the induction of antiviral activity against VSV (data not shown).
Since primary amines enhanced the anti-VSV activity of IFN, we were interested in determining their TGN enzyme-rich fractions from a sucrose gradient were pooled and diluted to 12 ml with 10 mN-HEPES, potassium hydroxide, pH 7-4 buffer containing 2 gg/ml each of the proteinase inhibitors, protonin, leupeptin and PMSF. Crude Golgi membranes were pelleted at 100000 g for 2 h, the supernatant was discarded and a discontinuous 10 to 40% Nycodenz gradient was layered onto the pellet. The gradient was centrifuged at 100000g for 10h and 500gl fractions were collected. The distribution of UDP-galactosyl-glycoprotein galactosyltransferase (O) and Noacetyl-B-glucosaminidase (&) was compared with that of protein (I-q). Fraction 1 is from the top of the gradient. (Table 1) . Similar results were seen in LB cells. t The increase in phi in treated cells over that of the control was calculated. Results are expressed as the change in pH units.
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:~ Student's t-test was used for statistical analysis. These values are highly significant ( P > 0-001) compared to those with either drug alone.
Determination of the intraeellular distribution of D A M P
D A M P , a b a s i c c o n g e n e r o f D N P , a c c u m u l a t e s in a c i d i c i n t r a c e l l u l a r c o m p a r t m e n t s , s u c h as t h e vesicles a n d c i s t e r n a e a s s o c i a t e d w i t h t h e T G N . LB cells w e r e t r e a t e d w i t h I F N a n d / o r C H L , a n d t h e d i s t r i b u t i o n o f D A M P w a s d e t e r m i n e d b y f l u o r e s c e n c e m i c r o s c o p y , u s i n g a n a n t i -D N P a n t i b o d y f o l l o w e d b y a f l u o r e s c e i n -c o u p l e d r a b b i t a n t i -m o u s e a n t i b o d y . D A M P w a s l o c a l i z e d in large p e r i n u c l e a r v a c u o l e s t h r o u g h o u t t h e c y t o p l a s m o f u n t r e a t e d cells (Fig. 6a) , b u t i n h i b i t i o n o f t h e u p t a k e o f D A M P i n t o t h e s e v a c u o l e s in I F N -or C H L -t r e a t e d cells w a s s e e n (Fig. 6b, (Fig.  6 d ) , s u g g e s t i n g t h a t t h e i n c r e a s e in p H o f t h e c y t o p l a s - 
e). T h i s i n h i b i t i o n o f D A M P u p t a k e w a s g r e a t e r in cells t r e a t e d w i t h b o t h I F N a n d C H L
Inhibition of 1FN-induced intracellular alkalinization by amiloride
Since amiloride is a specific inhibitor of Na+/H ÷ antiporters, we used it to assess whether an Na+/H + antiporter is involved in the IFN-induced changes in pHi. The pHi was studied in HeLa cells treated with 2 x 10 -4 M-amiloride and/or human IFN-a2a (100 IU/ml) for 16 h. As shown previously, IFN caused a significant rise in pHi (0-8 units); however, amiloride completely reversed this increase in pHi ( Table 2 ), suggesting that IFN had activated an Na+/H + antiporter system which caused the rise in pHi. A similar reversal of an IFNinduced increase in phi by amiloride was seen in mouse L8 clone 11. As also reported by other workers (Harootunian et al., 1989) , the increase in pHi in L8 and HeLa cells caused by primary amines was amilorideinsensitive (data not shown).
Increase in [Na~ caused by IFN treatment
The previous experiment suggested that IFN treatment activated the Na+/H ÷ antiporter, so inducing pHi changes. The Na+/H ÷ antiporter systems regulate the influx of Na ÷ and efflux of H ÷ ions; therefore, an increase in [Nai +] suggests that the Na+/H + antiporters have been activated. [Nai +] was measured using SBFI, a sodium-binding fluorescent indicator which is a selective chelator and discriminates against K+/H +, and which is unaffected at physiological concentrations of these ions. 1748 + 20 * Cells were treated for 16 h with human IFN-~za and washed three times. Cells were then incubated with 10 ~tM-SBF1 containing 0.1% pluronic acid for 90 rain at 37 °C and the fluorescence was measured after removing the excess unloaded dye.
~" Six fields (30 to 72 cells) were scanned in each experiment and the data represent the average fluorescence from six individual experiments.
The average fluorescence in IFN-treated cells increased significantly compared to that in untreated cells (Table  3 ), indicating that the [Na~ was increased by IFN treatment. This increase in [Na~ again suggested the activation of a Na+/H + antiporter system by IFN.
Discussion
Primary amines, such as NH4C1, CHL, DCA and MAM, are weak bases and acidotropic agents (Ohkuma & Poole, 1978; Seglan, 1983) ; when added to the medium of cells, the neutral forms of the compound rapidly cross the cellular membrane, are protonated and trapped in the acidic compartments, and result in a rise in the pHi. Although NH4C1 is not a primary amine, it is a weak base and thus behaves like a primary amine. These lysosomotropic amines interrupt recycling of receptors by inhibiting the intracellular transport of secretory and membrane proteins to the plasma membrane by raising the pH of the acidic Golgi body (Seglan, 1983; Matlin, 1986) .
NH4C1 inhibits the multiplication of HSV-1 at a late stage of infection (Helenius et al., 1980) . CHL also inhibits the replication and initial uncoating of virions of Semliki Forest virus and HSV-1 (Koyama & Uchida, 1989) . VSV G is synthesized and glycosylated in the presence of CHL; however, the expression of G at the cell surface during the final stages of G assembly is prevented (Dille & Johnson, 1982) .
Previous studies in our laboratory have shown that IFN treatment inhibits the transport of VSV G from the Golgi complex to the plasma membrane (Singh et al., 1988) . Recent experiments using sucrose and Nycodenz gradient fractionation have shown that most VSV G from IFN-treated cells accumulates in TGN-enriched fractions. Immunoprecipitated G from the TGN is endo H-resistant, but the terminal sialic acid had been added to G because it could be digested with neuraminidase.
These results confirm our previous finding (Singh et al., 1988) that VSV G accumulates in the TGN in IFNtreated cells. Recently, Panigrahi & Mohanty (1989) have shown defective transport of the haemagglutininneuraminidase glycoprotein of bovine PIV-3 in IFNtreated bovine nasal turbinate cells.
The resting pHi of a normal cell is almost neutral; however, the internal pH of organelles such as the endoplasmic reticulum, Golgi complex, endosomes, receptosomes and lysosomes is normally acidic, the TG N being the most acidic compartment, and very sensitive to most acidotropic agents (Anderson & Pathak, 1985; Matlin, 1986) . Using SNARF-I, we have shown that IFN significantly induces cytoplasmic alkalinization; a similar increase in pHi has been shown using mouse IFN-~/fl on tumours in vivo (Proietti et al., 1986) .
Kinetic studies have revealed that treatment of cells with IFN for 9 to 12 h is required to give an optimal increase in pHi. This correlates closely with the induction of the anti-VSV activity of IFN. The inhibition of DAMP localization to the Golgi apparatus in IFN-treated cells, as revealed by immunofluorescence, also indicates a significant rise in the pHi. Low concentrations of IFN or primary amine alone neither raise the pHi nor inhibit the transport of G to the plasma membrane significantly, but treatment with both IFN and primary amines raises the pHi significantly and blocks the transport of G to the plasma membrane. These studies suggest that an acidic environment could be important for the transport of VSV G. Proteins and other ligands destined for delivery by transporting vesicles generally associate with their receptor at a neutral pH. If this dissociation is prevented by an 1FN-induced elevation of pHi (i) the receptor-ligand complex might not reach the targeted vesicles, (ii) the receptorligand complex may be trapped in the targeting vesicles, thus effectively interrupting receptor recycling or (iii) the receptors that are normally degraded rather than recycled could be protected against degradation. IFN may, therefore, have acted in these cells by raising the pH in the TGN, thus inhibiting transport of G to the plasma membrane. Electron microscopy studies are in progress to localize DAMP distribution in the TGN of IFN-treated cells.
Protein kinase C (PKC) is well known as an activator of an Na+/H + antiporter system (Pouyssegur et al., 1988) and a recent report has demonstrated that human IFNs activate the translocation of PKC to the plasma membrane (Pfeffer & Reich, 1989) . Our results show a significant increase in [Nai +] in cells treated with IFN. Furthermore, amiloride, an inhibitor of the Na+/H + antiporter (Frelin et al., 1987) , reverses the IFN-induced alkalinization, suggesting a role for the Na+/H + antiporter system in IFN-induced pH changes. Other growth factors such as mitogens, human interleukin 1 and IFN-y also increase the phi by activating the Na+/H + antiporter in fibroblasts, murine T cells and macrophages respectively (Civitelli et al., 1989; Schuldiner & Rozengurt, 1982) . However, the present results suggest that IFN-c%-induced activation of the Na+/H + antiporter is slow compared to that of other growth factors.
The 2'-5'-oligoadenylate system (2-5A) is one possible biochemical pathway by which IFN treatment could produce diverse actions (Kerr & Brown, 1978) . In fact, the 2-5A system has been implicated in the inhibition of EMCV by IFN; however neither CHL nor NH4C1 has any effect on the induction of 2-5A synthetase (Branaca et al., 1982; Mounira & Thang, 1985) , and primary amines do not enhance the antiviral activity of IFN against EMCV, a virus with no membrane component. These results suggest that 2-5A probably is not involved in the enhancement of the antiviral activity of IFN by primary amines.
